← Back to Clinical Trials
RecruitingNCT06772038

Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionHemodynamic
SponsorBicetre Hospital
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment64
SexALL
Min Age18 Years
Max Age99 Years
Start Date2025-01-05
Completion2025-06-30

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Fluid responsiveness is a critical determinant guiding fluid therapy in critically ill patients. However, excessive fluid administration can result in fluid overload, leading to venous congestion and worse clinical outcomes. Venous congestion, a marker of impaired fluid clearance, is increasingly recognized as a significant contributor to poor prognosis. Previous studies have demonstrated the coexistence of fluid responsiveness and venous congestion in critically ill patients. Notably, these studies were limited by the absence of fluid challenge-the gold standard for assessing fluid responsiveness-leaving the dynamic relationship between fluid responsiveness and venous congestion incompletely understood. This study aims to investigate the interplay and temporal evolution of fluid responsiveness and venous congestion following a standardized fluid challenge in critically ill patients.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years * Hospitalized in the intensive care unit (ICU) * Hemodynamic monitoring in place, with a pulse wave contour analysis- derived estimation of cardiac output (either calibrated or uncalibrated) * Decision made by clinicians to perform volume expansion through intravenous infusion of crystalloid fluid Exclusion Criteria: * Pregnancy * Refusal to participate by relatives of the patient or the patient himself

Related Trials